A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

NCT07532902 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Pleural Mesothelioma
Gastroesophageal Carcinoma
Urothelial Carcinoma

Interventions

DRUG: BMS-986504
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: 5-FU
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Gemcitabine
DRUG: Platinum

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]